Though the overall picture is ambiguous, these tend to suggest that the cerebrospinal fluid (CSF) concentrations of phosphorylated and total tau are modestly elevated in those with hearing loss, but that there is little association between hearing loss and levels of CSF or PET Aβ.34–36. This evidence concerns the gene MAPT and hearing loss disorder.